Figure 3.
Figure 3. Clinical outcomes after myeloablative conditioning HCT by donor source. Clinical outcomes after dCBT, MRD, MUD, and MMUD transplantation. (A) LFS. (B) Relapse. (C) Nonrelapse mortality. (D) Neutrophil engraftment. (E) Platelet engraftment. (F) Grade 2-4 acute GVHD. Reprinted with permission from Brunstein et al.39

Clinical outcomes after myeloablative conditioning HCT by donor source. Clinical outcomes after dCBT, MRD, MUD, and MMUD transplantation. (A) LFS. (B) Relapse. (C) Nonrelapse mortality. (D) Neutrophil engraftment. (E) Platelet engraftment. (F) Grade 2-4 acute GVHD. Reprinted with permission from Brunstein et al.39 

Close Modal

or Create an Account

Close Modal
Close Modal